Share
Tweet
Share
Share
Share
Now Enrolling - 50 Model Solid Tumor
PDX In Vivo Screen
Participate in the Champions Oncology PDX Indication Screen for
lower cost
, large scale
PDX pharmacology studies
50 Clinically Relevant PDX Models -
View Characterization Data
;
- Breast
- Gastric
- Bladder
- Cholangiocarcinoma
- Hepatocellular Carcinoma
Enrollment Open Now - August 31st -
Models available on a first-come first-served basis.
The details on the
Champions' Solid Tumor PDX In Vivo Screen
are detailed below:
- NGS Data (WES and RNASeq) is freely available for all models
- Free FFPE/Snap frozen samples available at no cost for target validation
Significant cost savings compared to stand-alone studies
No minimum enrollment
Patient treatment history and PDX drug response data available
Free
terminal tumor collections
Flow cytometry, IHC and Nanostring gene expression analysis available
Enrollment period ends August 31st, 2019
Please contact Mandy Lehmann today at
mlehmann@championsoncology.com
or +41 78 307 90 55 for more information
x
Click the Share button below!
Share
Email Marketing
by ActiveCampaign